Page 5 - Qdel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Qdel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Qdel Today - Breaking & Trending Today

QuidelOrtho Co. (NASDAQ:QDEL) Given Average Rating of "Moderate Buy" by Analysts

QuidelOrtho Co. (NASDAQ:QDEL – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating on […] ....

Raymond James , William Blair , Quidelortho Company Profile , Clearbridge Investments , Quidelortho Co , Royal Bank , Neuberger Berman Group , Quidelortho Corporation , Burgundy Asset Management Ltd , Norges Bank , Get Free Report , Marketbeat Ratings , Berman Group , Asset Management , Get Free , Ortho Corporation , Transfusion Medicine , Molecular Diagnostics , Quidelortho Daily , Nasdaq Qdel ,

QuidelOrtho's (QDEL) "Neutral" Rating Reiterated at Citigroup

Citigroup restated their neutral rating on shares of QuidelOrtho (NASDAQ:QDEL – Free Report) in a report issued on Monday morning, MarketBeat.com reports. They currently have a $72.00 price objective on the stock, down from their prior price objective of $95.00. Other equities research analysts have also issued reports about the stock. Raymond James dropped their […] ....

Raymond James , William Blair , Royal Bank , First Horizon Advisors Inc , Quidelortho Corporation , Global Retirement Partners , Money Concepts Capital Corp , Mendota Financial Group , Eagle Bay Advisors , Free Report , Moderate Buy , Get Free Report , Concepts Capital Corp , Retirement Partners , Bay Advisors , Horizon Advisors , Ortho Corporation , Transfusion Medicine , Molecular Diagnostics , Quidelortho Daily , Nasdaq Qdel , Reiterated Rating , Citigroup Inc ,

QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Bridgewater Associates LP

Bridgewater Associates LP lowered its position in QuidelOrtho Co. (NASDAQ:QDEL – Free Report) by 9.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 54,277 shares of the company’s stock after selling 5,763 shares during the quarter. Bridgewater Associates LP owned about 0.08% of QuidelOrtho […] ....

United Kingdom , William Blair , Raymond James , Us Bancorp , Exchange Commission , Jpmorgan Chase Co , Quidelortho Corporation , Raymond James Financial Services Advisors Inc , Quidelortho Co , Royal Bank , Raymond James Associates , Cambridge Investment Research Advisors Inc , Healthcare Of Ontario Pension Plan Trust Fund , Bridgewater Associates , Free Report , James Financial Services Advisors , Investment Research Advisors , Ontario Pension Plan Trust Fund , Ortho Stock Down , Get Free Report , Ortho Corporation , Transfusion Medicine , Molecular Diagnostics , Visit Holdingschannel , Quidelortho Daily , Nasdaq Qdel ,

Covestor Ltd Sells 856 Shares of QuidelOrtho Co. (NASDAQ:QDEL)

Covestor Ltd lessened its stake in QuidelOrtho Co. (NASDAQ:QDEL – Free Report) by 29.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,022 shares of the company’s stock after selling 856 shares during the period. Covestor Ltd’s holdings in QuidelOrtho were worth […] ....

William Blair , Raymond James , Covestor Ltd , Us Bancorp , Eagle Bay Advisors , Mendota Financial Group , Quidelortho Co , Quidelortho Corporation , Money Concepts Capital Corp , Royal Bank , Jpmorgan Chase Co , First Horizon Advisors Inc , Free Report , Concepts Capital Corp , Bay Advisors , Horizon Advisors , Financial Group , Get Free Report , Ortho Corporation , Transfusion Medicine , Molecular Diagnostics , Visit Holdingschannel , Quidelortho Daily , Nasdaq Qdel , Sec Filings , Hedge Fund Holdings ,

QuidelOrtho (NASDAQ:QDEL) Updates FY 2023 Earnings Guidance

QuidelOrtho (NASDAQ:QDEL – Get Free Report) updated its FY 2023 earnings guidance on Thursday. The company provided earnings per share guidance of $4.85-$5.30 for the period, compared to the consensus earnings per share estimate of $4.90. The company issued revenue guidance of $2.88 billion-$3.08 billion, compared to the consensus revenue estimate of $2.98 billion. QuidelOrtho […] ....

Raymond James , Stonepine Capital Management , Renaissance Technologies , Norges Bank , Quidelortho Corporation , Envestnet Asset Management Inc , Quidelortho Company Profile , Jpmorgan Chase Co , Royal Bank , Get Free Report , Moderate Buy , Capital Management , Street Corp , Envestnet Asset Management , Asset Management , Ortho Corporation , Transfusion Medicine , Molecular Diagnostics , Quidelortho Daily , Nasdaq Qdel ,